The concentration ranges of the standard curves were 0.002-1 mg/L for piperacillin, 0.004-2 mg/L for ciprofloxacin, 0.008-4 mg/L for meropenem, and 0.2-40 mg/L for tazobactam.
The concentration range of the standard curve was 5-50 mg/L. The coefficients of variation for interassay and intra-assay precision were <10% for all of the assays.
Free (unbound to plasma protein) concentrations were not measured because previous data suggests that the free concentration is reliably calculated in antibiotics with a relatively low degree of protein binding, as noted with those used here [2] .
Population pharmacokinetic model development and evaluation
The time-course of each of the antibiotics in plasma was best described by a onecompartment linear model with zero order input of drug. BSV was described for both CL and Vd. The RUV was described using a combined proportional and additive variability model for meropenem and vancomycin, proportional error model for piperacillin and tazobactam and an additive error model for ciprofloxacin. The goodness of fit plots for each final model were evaluated and showed acceptable results in terms of visual or statistical biases for the prediction. 
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